Bellan, C <br/><br/>
Suramin inhibits vasoactive intestinal peptide (VIP) binding and VIP-induced cAMP accumulation into two human cancerous cell lines.  [electronic resource] 

 -  Second messengers and phosphoproteins  1991 
 - 163-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0895-7479 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cross-Linking Reagents<br/>Cyclic AMP--metabolism<br/>Humans<br/>Iodine Radioisotopes<br/>Isoproterenol--pharmacology<br/>Protein Binding<br/>Receptors, Gastrointestinal Hormone--chemistry<br/>Receptors, Vasoactive Intestinal Peptide<br/>Succinimides<br/>Suramin--pharmacology<br/>Tumor Cells, Cultured<br/>Vasoactive Intestinal Peptide--metabolism